AgomAb Therapeutics NV American Depositary Shares (AGMB) is a publicly traded the market company. As of October 1, 2026, AGMB trades at $11.52 with a market cap of $518.58M and a P/E ratio of 0.00. AGMB moved +3.76% today. Year to date, AGMB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $8.75 to $17.82. Analyst consensus is strong buy with an average price target of $34.80. Rallies surfaces AGMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AGMB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $11.52 |
| Market Cap | $518.58M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.82 |
| 52-Week Low | $8.75 |
| Volume | 2.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover AGMB: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.80.